8-K: Aemetis Reports Mixed 2023 Results with Strong Growth in India Biodiesel and Renewable Natural Gas Segments

Aemetis announced its 2023 fourth quarter and year-end results, highlighting significant revenue growth in its India biodiesel and California renewable natural gas segments, alongside challenges in its ethanol business.

Summary

• Aemetis reported a revenue of $70.8 million for the fourth quarter of 2023, up from $66.7 million in the same period of 2022.
• Full-year 2023 revenue reached $186.7 million, compared to $257 million in 2022, with the India biodiesel segment contributing $77.2 million and the California renewable natural gas segment adding $5.5 million.
• The company experienced a decrease in revenue from its California ethanol segment due to an extended maintenance and upgrade cycle at the Keyes plant.
• Capital expenditures for carbon intensity reduction and production expansion projects totaled $33 million in 2023.
• Aemetis repaid $50.2 million of Third Eye Capital debt in Q3 2023 and generated $32.7 million of positive cash flow from adjusted EBITDA plus IRA investment tax credit sales.
• The company secured $55 million from the sale of $63 million of IRA investment tax credits related to biogas projects.
• Aemetis closed $50 million in new credit facilities related to USDA guaranteed loans.
• The company increased its Aemetis Biogas commissioned production capacity by 300% during 2023.
• Aemetis received allocations for $184 million of biodiesel sales in India for 2023 and the first three quarters of 2024.
• The net loss for the fourth quarter of 2023 was $25.4 million, compared to a net loss of $22.4 million in the same period of 2022.
• The net loss for the full year 2023 was $46.4 million, a significant improvement from the $107.8 million loss in 2022.

Sentiment

Score: 5

Explanation: The document presents a mixed picture with strong growth in some segments offset by overall revenue decline and net losses. While there are positive developments, the financial results and future capital needs temper the overall sentiment.

Positives

• The India biodiesel segment showed substantial growth with a 175% increase in annual sales.
• Aemetis Biogas significantly increased its production capacity by 300%.
• The company successfully repaid a significant portion of its debt, reducing loan balances by $50.2 million.
• Aemetis generated positive cash flow of $32.7 million from adjusted EBITDA plus IRA investment tax credit sales.
• The company secured $55 million from the sale of IRA investment tax credits.
• Aemetis closed $50 million in new credit facilities related to USDA guaranteed loans.
• The company received allocations for $184 million of biodiesel sales in India.
• Aemetis expanded its India biodiesel production capacity to 60 million gallons per year ahead of schedule.
• The company's net loss improved significantly from $107.8 million in 2022 to $46.4 million in 2023.

Negatives

• The company experienced a decrease in overall revenue from $257 million in 2022 to $186.7 million in 2023.
• The California ethanol segment saw reduced revenue due to an extended maintenance and upgrade cycle at the Keyes plant.
• The company reported a net loss of $25.4 million for the fourth quarter of 2023 and $46.4 million for the full year.
• Cash at the end of the fourth quarter of 2023 was $2.7 million, down from $4.3 million at the end of 2022.
• Operating loss was $37.4 million for the twelve months ended December 31, 2023, compared to an operating loss of $34.4 million for the same period in 2022.
• Selling, general and administrative expenses increased to $39.3 million during the twelve months ended December 31, 2023, compared to $28.7 million during the same period in 2022.

Risks

• The company faces risks related to competition in the ethanol, biodiesel, and other industries.
• Commodity market risks, including those from weather conditions, could impact the company's performance.
• Financial market risks and counter-party risks could affect the company's operations.
• Changes to federal policy or regulation could pose challenges.
• The company's ability to fund, develop, build, maintain, and operate its various projects is subject to risks.
• The company's ability to receive awarded grants is contingent on meeting all required conditions.

Future Outlook

The company's future outlook includes the continued development of its sustainable aviation fuel and renewable diesel projects, expansion of its biogas network, and ongoing biodiesel sales in India. Aemetis also intends to repurchase the Series A preferred units relating to its Aemetis Biogas subsidiary.

Management Comments

• Todd Waltz, Chief Financial Officer, noted the growth in revenue from the India Biodiesel and California Renewable Natural Gas segments, along with the impact of the Keyes plant maintenance.
• Todd Waltz also mentioned the $33 million in capital expenditures for carbon intensity reduction and production expansion projects.
• Eric McAfee, Chairman and CEO, highlighted the achievement of operational milestones and the closing of new credit facilities.

Industry Context

The announcement reflects the growing focus on renewable fuels and natural gas, aligning with industry trends towards low and negative carbon intensity products. The company's expansion in biogas and sustainable aviation fuel positions it to capitalize on increasing demand for these alternatives to traditional fossil fuels. The company's focus on carbon capture and sequestration also aligns with broader industry efforts to reduce greenhouse gas emissions.

Comparison to Industry Standards

• Aemetis's 175% growth in India biodiesel sales is significantly higher than the average growth rate in the global biodiesel market, which is estimated to be around 5-10% annually, indicating a strong performance in this segment.
• The company's 300% increase in biogas production capacity is a substantial achievement compared to typical biogas project expansions, which often see more incremental growth.
• The $32.7 million in positive cash flow from adjusted EBITDA plus IRA investment tax credit sales is a positive sign, but the overall net loss of $46.4 million for the year is a concern when compared to more profitable peers in the renewable fuels sector, such as Neste or Renewable Energy Group, which have demonstrated consistent profitability.
• The company's capital expenditures of $33 million are significant, but the impact on future revenue and profitability will need to be monitored against industry benchmarks for similar projects.
• The company's ethanol production capacity utilization of 58% for the year is below the industry average, which is typically above 80%, indicating room for improvement in this segment.

Stakeholder Impact

• Shareholders may be concerned about the net loss and decreased cash position, but encouraged by the growth in certain segments and debt reduction.
• Employees may be impacted by the company's financial performance and future growth plans.
• Customers in India will benefit from the increased biodiesel production capacity.
• Suppliers of corn and other feedstocks may see changes in demand based on the company's production levels.
• Creditors will be impacted by the company's debt repayment and refinancing activities.

Next Steps

• The company will host an earnings review call at 11:00 a.m. Pacific time (PT) on March 7, 2024.
• Investors are invited to review the updated Aemetis Five Year Plan on the company's website.
• The company will continue to develop its sustainable aviation fuel and renewable diesel projects.
• Aemetis will continue to expand its biogas network and pursue ongoing biodiesel sales in India.

Key Dates

Keywords

Renewable Natural Gas, Biodiesel, Ethanol, Sustainable Aviation Fuel, Carbon Capture, Aemetis Biogas, Renewable Diesel, IRA Investment Tax Credits, USDA Loans, D3 RINs